NEW YORK, Sept. 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
U.S. Market for In-Vitro Diagnostics 2011
http://www.reportlinker.com/p0610526/US-Market-for-In-Vitro-Diagnostics-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
By 2017, the U.S. in vitro diagnostic market is expected to approach $10 billion. The market segments covered in the U.S. Markets for In Vitro Diagnostics 2011 include:
- Immunochemistry,
- Immunochemistry Analyzer
- Immunology Diagnostic
- Chemistry Diagnostics
- Automated Urinalysis Instrument
- Molecular Diagnostics
- Molecular Diagnostics Reagent
- Molecular Diagnostics Instrument
- Hemostasis
- Hemostasis Analyzer
- Hemostasis Reagent
- Hematology
- Hematology Analyzer Market
- Hematology Reagent
- Blood Donor Screening
- Blood Screening Analyzer
- Blood Screening Assay Kit
- Point-of-Care Testing
- Blood Gas Testing
- Urinalysis Testing
- Blood Glucose Testing
In 2010, the U.S. in vitro diagnostics market experienced significant growth due to the introduction of new Food and Drug Administration (FDA) approved assays. That year, many technologies were well established and equipment markets were saturated. However, innovation, demand for testing and development of new assays will drive market growth.
Within the in vitro diagnostics market, companies such as Siemens, Roche Diagnostics, Abbott Diagnostics and Beckman Coulter lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
The executive summary of this report is also available for purchase.
TABLE OF CONTENTS
TABLE OF CONTENTS.I
LIST OF FIGURES.VI
LIST OF CHARTS..XI
EXECUTIVE SUMMARY 1
1.1 U.S.MARKET FOR IN VITRO DIAGNOSTICS 1
1.2 GROWTH TRENDS BY SEGMENT .. 2
1.3 IMMUNOCHEMISTRY MARKET.. 3
1.4MOLECULAR DIAGNOSTICS MARKET 4
1.5 BLOOD DONOR SCREENING MARKET 5
1.6 HEMOSTASIS MARKET.. 6
1.7 HEMATOLOGY MARKET .. 7
1.8 POINT-OF-CARE TESTING MARKET 8
1.9 COMPETITIVE ANALYSIS . 9
RESEARCH METHODOLOGY 10
2.1 RESEARCH SCOPE . 10
2.2 IDATA'S 9-STEP METHODOLOGY . 10
2.2.1 Step 1: Project Initiation & Team Selection 11
2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research 12
2.2.3 Step 3: Preparation for Interviews & Questionnaire Design . 13
2.2.4 Step 4: Performing Primary Research 14
2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates . 16
2.2.6 Step 6: Market Forecast and Analysis 16
2.2.7 Step 7: Identify Strategic Opportunities 18
2.2.8 Step 8: Final Review and Market Release 19
2.2.9 Step 9: Customer Feedback and Market Monitoring.. 20
U.S. MARKET FOR IN VITRO DIAGNOSTICS .. 21
3.1 INTRODUCTION .. 21
3.2MARKET OVERVIEW 22
3.3 TREND ANALYSIS BY SEGMENT 27
3.4MARKET DRIVERS AND LIMITERS 30
3.4.1 Market Drivers 30
3.4.2 Market Limiters.. 32
3.5 COMPETITIVE ANALYSIS .. 34
3.5.1 Herfindahl Index 44
3.6MERGERS AND ACQUISITIONS 46
IMMUNOCHEMISTRY MARKET. 47
4.1 INTRODUCTION .. 47
4.2MARKET OVERVIEW 49
4.3MARKET ANALYSIS AND FORECAST .. 54
4.3.1 Immunochemistry Analyzer Market . 56
4.3.2 Immunoassay Market.. 59
4.3.2.1 Immunoassay Analyzer Market..61
4.3.2.2 Immunoassay Reagent Market64
4.3.3 Clinical Chemistry Market 78
4.3.3.1 Clinical Chemistry Analyzer Market ..80
4.3.3.1.1 High-Volume Clinical Chemistry Analyzer Market..83
4.3.3.1.2 Medium-Volume Clinical Chemistry Analyzer Market86
4.3.3.1.3 Low-Volume Clinical Chemistry Analyzer Market 89
4.3.3.2 Clinical Chemistry Reagent Market 92
4.3.4 Automated Urinalysis Analyzer Market.. 103
4.4MARKET DRIVERS AND LIMITERS . 106
4.4.1 Market Drivers. 106
4.4.2 Market Limiters 107
4.5 COMPETITIVE ANALYSIS 108
MOLECULAR DIAGNOSTICS MARKET. 113
5.1 INTRODUCTION 113
5.2MARKET OVERVIEW. 115
5.3MARKET ANALYSIS AND FORECAST 120
5.3.1 Molecular Diagnostics Instrument Market 122
5.3.2 Molecular Diagnostics Assay Market.. 125
5.3.2.1 Infectious Disease Assay Market 128
5.3.2.1.1 Blood-Borne Virus Assay Market 131
5.3.2.1.2 Women's Health Assay Market.140
5.3.2.1.3 MRSA and CMV Assay Market.149
5.3.2.2 Genetic Diagnostics Assay Market156
5.3.2.3 Oncology Assay Market..162
5.4MARKET DRIVERS AND LIMITERS . 171
5.4.1 Market Drivers. 171
5.4.2 Market Limiters 171
5.5 COMPETITIVE ANALYSIS 173
BLOOD DONOR SCREENING MARKET . 180
6.1 INTRODUCTION 180
6.2MARKET OVERVIEW. 183
6.3MARKET ANALYSIS AND FORECAST 188
6.3.1.1 Blood Donor Screening Analyzer Market..190
6.3.1.2 Blood Donor Screening Assay Market.193
6.4MARKET DRIVERS AND LIMITERS . 204
6.4.1 Market Drivers. 204
6.4.2 Market Limiters 204
6.5 COMPETITIVE ANALYSIS 206
HEMOSTASIS MARKET 209
7.1 INTRODUCTION 209
7.2MARKET OVERVIEW. 212
7.3MARKET ANALYSIS AND FORECAST 217
7.3.1.1 Hemostasis Analyzer Market 219
7.3.1.2 Hemostasis Reagent Market .222
7.4MARKET DRIVERS AND LIMITERS . 225
7.4.1 Market Drivers. 225
7.4.2 Market Limiters 226
7.5 COMPETITIVE ANALYSIS 227
HEMATOLOGY MARKET .. 230
8.1 INTRODUCTION 230
8.2MARKET OVERVIEW. 231
8.3MARKET FORECAST AND ANALYSIS 236
8.3.1 Hematology Analyzer Market .. 238
8.3.1.1 High-End Analyzer Market241
8.3.1.2 Low-End Analyzer Market.244
8.3.2 Hematology Reagent Market 247
8.4MARKET DRIVERS AND LIMITERS . 250
8.4.1 Market Drivers. 250
8.4.2 Market Limiters 250
8.5 COMPETITIVE ANALYSIS 252
POINT-OF-CARE TESTING MARKET .. 256
9.1 INTRODUCTION 256
9.2MARKET OVERVIEW. 259
9.3MARKET ANALYSIS AND FORECAST 265
9.3.1 Clinical Chemistry Market. 267
9.3.1.1 Clinical Chemistry Analyzer Market 269
9.3.1.2 Clinical Chemistry Reagent Market .272
9.3.2 Blood Gas Testing Market . 275
9.3.2.1 Blood Gas Analyzer Market..277
9.3.2.1.1 Handheld Blood Gas Analyzer Market .280
9.3.2.1.2 Decentralized Blood Gas Analyzer Market 283
9.3.2.2 Blood Gas Reagent Market286
9.3.3 Point-of-Care Urinalysis Market 295
9.3.3.1 Urinalysis Analyzer Market..297
9.3.3.2 Urinalysis Test Strip Market.300
9.3.4 Point-of-Care Blood Glucose Testing Market . 303
9.3.4.1 POC Blood Glucose Analyzer Market .305
9.3.4.2 POC Blood Glucose Test Strip Market308
9.4MARKET DRIVERS AND LIMITERS . 311
9.4.1 Market Drivers. 311
9.4.2 Market Limiters 312
9.5 COMPETITIVE ANALYSIS 314
ABBREVIATIONS 320
APPENDIX: MARKET BREAKDOWN BY TESTING SETTING . 322
LIST OF FIGURES
EXECUTIVE SUMMARY 1
RESEARCH METHODOLOGY.. 10
U.S. MARKET FOR IN VITRO DIAGNOSTICS 21
Figure 3-1: Total In Vitro Diagnostics Market by Segment, U.S., 2007 – 2017
(US$M) 23
Figure 3-2: Growth Rates by Segment, In Vitro Diagnostics Market, U.S.,
2007 – 2017 28
Figure 3-3: Market Drivers and Limiters, In Vitro Diagnostics Market, 2010. 33
Figure 3-4: Leading Competitors, In Vitro Diagnostics Market, 2010
(Part 1 of 2) 41
Figure 3-5: Leading Competitors, In Vitro Diagnostics Market, 2010
(Part 2 of 2) 42
Figure 3-6: H-Index, In Vitro Diagnostics Market, U.S., 2010.. 44
IMMUNOCHEMISTRY MARKET 47
Figure 4-1: Total Immunochemistry Market by Segment, U.S., 2007 – 2017
(US$M) 50
Figure 4-2: Total Immunochemistry Market, U.S., 2007 – 2017 54
Figure 4-3: Immunochemistry Analyzer Market, U.S., 2007 – 2017 57
Figure 4-4: Total Immunoassay Market, U.S., 2007 – 2017 59
Figure 4-5: Immunoassay Analyzer Market, U.S., 2007 – 2017 62
Figure 4-6: Immunoassay Market Test Groups . 65
Figure 4-7: Total Immunoassay Reagent Market, U.S., 2007 – 2017 .. 66
Figure 4-8: Immunoassay Tests Sold by Segment, U.S., 2007 – 2017 67
Figure 4-9: Immunoassay Reagent ASP by Segment, U.S., 2007 – 2017 (US$) . 68
Figure 4-10: Immunoassay Reagent Market by Segment, U.S., 2007 – 2017
(US$M) 69
Figure 4-11: Total Clinical Chemistry Market, U.S., 2007 – 2017 .. 78
Figure 4-12: Total Clinical Chemistry Analyzer Market, U.S., 2007 – 2017 81
Figure 4-13: High-Volume Clinical Chemistry Analyzer Market, U.S., 2007 – 2017
84
Figure 4-14: Medium-Volume Clinical Chemistry Analyzer Market, U.S.,
2007 – 2017 87
Figure 4-15: Low-Volume Clinical Chemistry Analyzer Market, U.S.,
2007 – 2017 90
Figure 4-16: Total Clinical Chemistry Reagent Market, U.S., 2007 – 2017 . 93
Figure 4-17: Clinical Chemistry Tests Sold by Segment, U.S., 2007 – 2017 94
Figure 4-18: Clinical Chemistry Reagent ASP by Segment, U.S., 2007 – 2017.. 95
Figure 4-19: Clinical Chemistry Reagent Market by Segment, U.S., 2007 – 2017
(US$M) 96
Figure 4-20: Automated Urinalysis Instrument Market, U.S., 2007 – 2017 104
Figure 4-21: Market Drivers and Limiters, Immunochemistry Market, 2010. 107
Figure 4-22: Leading Competitors, Immunochemistry Market, 2010 111
MOLECULAR DIAGNOSTICS MARKET.. 113
Figure 5-1: Total Molecular Diagnostics Market by Segment, U.S., 2007 – 2017
(US$M) . 116
Figure 5-2: Total Molecular Diagnostics Market, U.S., 2007 – 2017 120
Figure 5-3: Molecular Diagnostics Instrument Market, U.S., 2007 – 2017 123
Figure 5-4: Total Molecular Diagnostics Assay Market, U.S., 2007 – 2017.. 126
Figure 5-5: Total Infectious Disease Assay Market, U.S., 2007 – 2017 .. 129
Figure 5-6: Total Blood-Borne Virus Assay Market, U.S., 2007 – 2017 . 132
Figure 5-7: Blood-Borne Virus Tests Sold by Segment, U.S., 2007 – 2017 .. 133
Figure 5-8: Blood-Borne Virus Assay ASP by Segment, U.S., 2007 – 2017
(US$) . 134
Figure 5-9: Blood-Borne Virus Assay Market by Segment, U.S., 2007 – 2017
(US$M) . 135
Figure 5-10: Total Women's Health Assay Market, U.S., 2007 – 2017 141
Figure 5-11: Total Women's Health Tests Sold by Segment, U.S., 2007 – 2017 . 142
Figure 5-12: Total Women's Health Assay ASP by Segment, U.S., 2007 – 2017
(US$) . 143
Figure 5-13: Total Women's Health Assay Market by Segment, U.S., 2007 – 2017
(US$M) . 144
Figure 5-14: Total MRSA and CMV Assay Market, U.S., 2007 – 2017 .. 150
Figure 5-15: Total MRSA and CMV Tests Sold by Segment, U.S.,
2007 – 2017. 151
Figure 5-16: Total MRSA and CMV Assay ASP by Segment, U.S., 2007 – 2017
(US$) . 151
Figure 5-17: Total MRSA and CMV Market by Segment, U.S., 2007 – 2017
(US$M) . 152
Figure 5-18: Total Genetic Diagnostics Assay Market, U.S., 2007 – 2017. 157
Figure 5-19: Total Genetic Diagnostics Tests Sold by Segment, U.S.,
2007 – 2017. 157
Figure 5-20: Total Genetic Diagnostics Assay ASP by Segment, U.S.,
2007 – 2017. 158
Figure 5-21: Total Genetic Diagnostics Assay Market by Segment, U.S.,
2007 – 2017 (US$M) .. 158
Figure 5-22: Total Oncology Assay Market, U.S., 2007 – 2017 . 163
Figure 5-23: Total Oncology Tests Sold by Segment, U.S., 2007 – 2017 164
Figure 5-24: Total Oncology Assay ASP by Segment, U.S., 2007 – 2017
(US$) . 165
Figure 5-25: Total Oncology Assay Market by Segment, U.S., 2007 – 2017
(US$M) . 166
Figure 5-26: Market Drivers and Limiters, Molecular Diagnostics Market,
2010 172
Figure 5-27: Leading Competitors, Molecular Diagnostics Market, 2010 .. 178
BLOOD DONOR SCREENING MARKET.. 180
Figure 6-1: Total Blood Donor Screening Market by Segment, U.S., 2007 – 2017
(US$M) . 184
Figure 6-2: Total Blood Donor Screening Market, U.S., 2007 – 2017 . 188
Figure 6-3: Blood Donor Screening Analyzer Market, U.S., 2007 – 2017.. 191
Figure 6-4: Total Blood Donor Screening Assay Market, U.S., 2007 – 2017 194
Figure 6-5: Blood Donor Screening Units Sold by Segment, U.S., 2007 – 2017 . 195
Figure 6-6: Blood Donor Screening Assay ASP by Segment, U.S., 2007 – 2017
(US$) . 196
Figure 6-7: Blood Donor Screening Assay Market by Segment, U.S., 2007 – 2017
(US$M) . 197
Figure 6-8: Market Drivers and Limiters, Blood Donor Screening Market,
2010 205
Figure 6-9: Leading Competitors, Blood Donor Screening Market, 2010 .. 207
HEMOSTASIS MARKET 209
Figure 7-1: Hemophilia Classification .. 210
Figure 7-2: Total Hemostasis Market by Segment, U.S., 2007 – 2017 (US$M) 213
Figure 7-3: Total Hemostasis Market, U.S., 2007 – 2017.. 217
Figure 7-4: Hemostasis Analyzer Market, U.S., 2007 – 2017 .. 220
Figure 7-5: Hemostasis Reagent Market, U.S., 2007 – 2017 223
Figure 7-6: Market Drivers and Limiters, Hemostasis Market, 2010 226
Figure 7-7: Leading Competitors, Hemostasis Market, 2010 228
HEMATOLOGY MARKET 230
Figure 8-1: Total Hematology Market by Segment, U.S., 2007 – 2017 (US$M).. 232
Figure 8-2: Total Hematology Market, U.S., 2007 – 2017 236
Figure 8-3: Total Hematology Analyzer Market, U.S., 2007 – 2017 . 239
Figure 8-4: High-End Analyzer Market, U.S., 2007 – 2017 . 242
Figure 8-5: Low-End Analyzer Market, U.S., 2007 – 2017 .. 245
Figure 8-6: Hematology Reagent Market, U.S., 2007 – 2017 .. 248
Figure 8-7: Market Drivers and Limiters, Hematology Market, 2010 .. 251
Figure 8-8: Leading Competitors, Hematology Market, 2010.. 254
POINT-OF-CARE TESTING MARKET 256
Figure 9-1: Total POC Testing Market by Segment, U.S., 2007 – 2017
(US$M) . 260
Figure 9-2: Total POC Testing Market Segments by Percentage, U.S.,
2007 – 2017. 261
Figure 9-3: Total POC Testing Market by Product Type, U.S., 2007 – 2017. 261
Figure 9-4: Total POC Testing Market, U.S., 2007 – 2017 .. 265
Figure 9-5: Clinical Chemistry Market, U.S., 2007 – 2017 .. 267
Figure 9-6: Clinical Chemistry Analyzer Market, U.S., 2007 – 2017 270
Figure 9-7: Clinical Chemistry Reagent Market, U.S., 2007 – 2017 . 273
Figure 9-8: Blood Gas Testing Market, U.S., 2007 – 2017 275
Figure 9-9: Total Blood Gas Analyzer Market, U.S., 2007 – 2017 278
Figure 9-10: Handheld Blood Gas Analyzer Market, U.S., 2007 – 2017 . 281
Figure 9-11: Decentralized Blood Gas Analyzer Market, U.S., 2007 – 2017. 284
Figure 9-12: Total Blood Gas Reagent Market, U.S., 2007 – 2017 287
Figure 9-13: Blood Gas Reagent Units Sold by Packaging Type Market, U.S.,
2007 – 2017. 288
Figure 9-14: Blood Gas Reagent ASP by Packaging Type Market, U.S.,
2007 – 2017 (US$) 289
Figure 9-15: Blood Gas Reagent Market by Packaging Type, U.S., 2007 – 2017
(US$M) . 290
Figure 9-16: POC Urinalysis Market, U.S., 2007 – 2017 .. 295
Figure 9-17: Urinalysis Analyzer Market, U.S., 2007 – 2017.. 298
Figure 9-18: POC Urinalysis Test Strip Market, U.S., 2007 – 2017 . 301
Figure 9-19: POC Blood Glucose Testing Market, U.S., 2007 – 2017 . 303
Figure 9-20: POC Blood Glucose Analyzer Market, U.S., 2007 – 2017 .. 306
Figure 9-21: POC Blood Glucose Test Strip Market, U.S., 2007 – 2017. 309
Figure 9-22: Market Drivers and Limiters, Point-of-Care Testing Market,
2010 313
Figure 9-23: Leading Competitors, Point-of-Care Testing Market, 2010 318
ABBREVIATIONS 320
APPENDIX: MARKET BREAKDOWN BY TESTING SETTING 322
Figure 11-1: Market Proportion by Testing Setting, 2010 . 322
LIST OF CHARTS
EXECUTIVE SUMMARY 1
Chart 1-1: Total U.S. In Vitro Diagnostics Market by Segment, U.S., 2010 .. 1
Chart 1-2: Growth Rates by Segment, In Vitro Diagnostics Market, U.S.,
2007 – 2017.. 2
Chart 1-3: Immunochemistry Assay Volume Growth Rates by Segment, U.S.,
2007 – 2017.. 3
Chart 1-4: Infectious Disease Assay Market by Segment, U.S., 2010 4
Chart 1-5: Blood Donor Screening Market, U.S., 2010 .. 5
Chart 1-6: Hemostasis Market by Segment, U.S., 2010 6
Chart 1-7: Hematology Market by Segment, U.S., 2007 – 2017 .. 7
Chart 1-8: POC Testing Market, U.S., 2007 – 2017 .. 8
Chart 1-9: Leading Competitors, In Vitro Diagnostics Market, U.S., 2010 . 9
RESEARCH METHODOLOGY.. 10
U.S. MARKET FOR IN VITRO DIAGNOSTICS 21
Chart 3-1: Total In Vitro Diagnostics Market by Segment, U.S., 2007 – 2017 24
Chart 3-2: Total In Vitro Diagnostics Market by Segment, U.S., 2010 .. 25
Chart 3-3: Total In Vitro Diagnostics Market by Segment, U.S., 2017 .. 26
Chart 3-4: Growth Rates by Segment, In Vitro Diagnostics Market, U.S.,
2007 – 2017 29
Chart 3-5: Leading Competitors, In Vitro Diagnostics Market, 2010.. 43
Chart 3-6: H-Index, In Vitro Diagnostics Market, U.S., 2010 45
IMMUNOCHEMISTRY MARKET 47
Chart 4-1: Total Immunochemistry Market by Segment, U.S., 2007 – 2017 51
Chart 4-2: Total Immunochemistry Market by Segment, U.S., 2010 52
Chart 4-3: Total Immunochemistry Market by Segment, U.S., 2017 53
Chart 4-4: Total Immunochemistry Market, U.S., 2007 – 2017 . 55
Chart 4-5: Immunochemistry Analyzer Market, U.S., 2007 – 2017 . 58
Chart 4-6: Total Immunoassay Market, U.S., 2007 – 2017.. 60
Chart 4-7: Immunoassay Analyzer Market, U.S., 2007 – 2017 .. 63
Chart 4-8: Total Immunoassay Reagent Market, U.S., 2007 – 2017. 70
Chart 4-9: Cardiovascular Reagent Market, U.S., 2007 – 2017 . 71
Chart 4-10: Cancer Reagent Market, U.S., 2007 – 2017 72
Chart 4-11: Infectious Disease Reagent Market, U.S., 2007 – 2017 73
Chart 4-12: Metabolic Reagent Market, U.S., 2007 – 2017 . 74
Chart 4-13: Endocrine Reagent Market, U.S., 2007 – 2017 . 75
Chart 4-14: Reproductive and Fertility Reagent Market, U.S., 2007 – 2017 76
Chart 4-15: Autoimmune Reagent Market, U.S., 2007 – 2017 77
Chart 4-16: Total Clinical Chemistry Market, U.S., 2007 – 2017 . 79
Chart 4-17: Total Clinical Chemistry Analyzer Market, U.S., 2007 – 2017 . 82
Chart 4-18: High-Volume Clinical Chemistry Analyzer Market, U.S.,
2007 – 2017 85
Chart 4-19: Medium-Volume Clinical Chemistry Analyzer Market, U.S.,
2007 – 2017 88
Chart 4-20: Low-Volume Clinical Chemistry Analyzer Market, U.S.,
2007 – 2017 91
Chart 4-21: Total Clinical Chemistry Reagent Market, U.S., 2007 – 2017 97
Chart 4-22: General Chemistry Reagent Market, U.S., 2007 – 2017 98
Chart 4-23: Specific Protein Reagent Market, U.S., 2007 – 2017 . 99
Chart 4-24: Therapeutic Drug Monitoring Reagent Market, U.S., 2007 – 2017 100
Chart 4-25: Drugs of Abuse Reagent Market, U.S., 2007 – 2017 .. 101
Chart 4-26: Special Chemistry Reagent Market, U.S., 2007 – 2017.. 102
Chart 4-27: Automated Urinalysis Instrument Market, U.S., 2007 – 2017 . 105
Chart 4-28: Leading Competitors, Immunochemistry Market, 2010 . 112
MOLECULAR DIAGNOSTICS MARKET.. 113
Chart 5-1: Total Molecular Diagnostics Market by Segment, U.S.,
2007 – 2017. 117
Chart 5-2: Total Molecular Diagnostics Market by Segment, U.S., 2010 118
Chart 5-3: Total Molecular Diagnostics Market by Segment, U.S., 2017 119
Chart 5-4: Total Molecular Diagnostics Market, U.S., 2007 – 2017 . 121
Chart 5-5: Molecular Diagnostics Instrument Market, U.S., 2007 – 2017 .. 124
Chart 5-6: Total Molecular Diagnostics Assay Market, U.S., 2007 – 2017 127
Chart 5-7: Total Infectious Disease Assay Market, U.S., 2007 – 2017 130
Chart 5-8: Total Blood-Borne Virus Assay Market, U.S., 2007 – 2017 .. 136
Chart 5-9: HIV Assay Market, U.S., 2007 – 2017. 137
Chart 5-10: HCV Assay Market, U.S., 2007 – 2017. 138
Chart 5-11: HBV Assay Market, U.S., 2007 – 2017. 139
Chart 5-12: Total Women's Health Assay Market, U.S., 2007 – 2017 . 145
Chart 5-13: HPV Assay Market, U.S., 2007 – 2017 . 146
Chart 5-14: HSV Assay Market, U.S., 2007 – 2017 . 147
Chart 5-15: CT/GC Assay Market, U.S., 2007 – 2017. 148
Chart 5-16: Total MRSA and CMV Assay Market, U.S., 2007 – 2017. 153
Chart 5-17: MRSA Assay Market, U.S., 2007 – 2017 . 154
Chart 5-18: CMV Assay Market, U.S., 2007 – 2017 155
Chart 5-19: Total Genetic Diagnostics Assay Market, U.S., 2007 – 2017 .. 159
Chart 5-20: CF Assay Market, U.S., 2007 – 2017 . 160
Chart 5-21: Inherited Thrombophilia Assay Market, U.S., 2007 – 2017 . 161
Chart 5-22: Total Oncology Assay Market, U.S., 2007 – 2017 167
Chart 5-23: Breast Cancer Assay Market, U.S., 2007 – 2017 .. 168
Chart 5-24: Colorectal Cancer Assay Market, U.S., 2007 – 2017 .. 169
Chart 5-25: Prostate Cancer Assay Market, U.S., 2007 – 2017 170
Chart 5-26: Leading Competitors, Molecular Diagnostics Market, 2010. 179
BLOOD DONOR SCREENING MARKET.. 180
Chart 6-1: Total Blood Donor Screening Market by Segment, U.S.,
2007 – 2017. 185
Chart 6-2: Total Blood Donor Screening Market by Segment, U.S., 2010 . 186
Chart 6-3: Total Blood Donor Screening Market by Segment, U.S., 2017 . 187
Chart 6-4: Total Blood Donor Screening Market, U.S., 2007 – 2017 189
Chart 6-5: Blood Donor Screening Analyzer Market, U.S., 2007 – 2017 192
Chart 6-6: Blood Donor Screening Assay Market, U.S., 2007 – 2017.. 198
Chart 6-7: Combined Assay Market, U.S., 2007 – 2017. 199
Chart 6-8: WNV Assay Market, U.S., 2007 – 2017.. 200
Chart 6-9: HIV Assay Market, U.S., 2007 – 2017. 201
Chart 6-10: HCV Assay Market, U.S., 2007 – 2017. 202
Chart 6-11: HBV Assay Market, U.S., 2007 – 2017. 203
Chart 6-12: Leading Competitors, Blood Donor Screening Reagent Market, U.S.,
2007 – 2017. 208
HEMOSTASIS MARKET 209
Chart 7-1: Total Hemostasis Market by Segment, U.S., 2007 – 2017 .. 214
Chart 7-2: Total Hemostasis Market by Segment, U.S., 2010.. 215
Chart 7-3: Total Hemostasis Market by Segment, U.S., 2017.. 216
Chart 7-4: Total Hemostasis Market, U.S., 2007 – 2017 218
Chart 7-5: Hemostasis Analyzer Market, U.S., 2007 – 2017 221
Chart 7-6: Hemostasis Reagent Market, U.S., 2007 – 2017 .. 224
Chart 7-7: Leading Competitors, Hemostasis Market, 2010 . 229
HEMATOLOGY MARKET 230
Chart 8-1: Total Hematology Market by Segment, U.S., 2007 – 2017 . 233
Chart 8-2: Total Hematology Market by Segment, U.S., 2010. 234
Chart 8-3: Total Hematology Market by Segment, U.S., 2017. 235
Chart 8-4: Total Hematology Market, U.S., 2007 – 2017 .. 237
Chart 8-5: Total Hematology Analyzer Market, U.S., 2007 – 2017 .. 240
Chart 8-6: High-End Analyzer Market, U.S., 2007 – 2017 243
Chart 8-7: Low-End Analyzer Market, U.S., 2007 – 2017. 246
Chart 8-8: Hematology Reagent Market, U.S., 2007 – 2017. 249
Chart 8-9: Leading Competitors, Hematology Market, 2010 255
POINT-OF-CARE TESTING MARKET 256
Chart 9-1: Total POC Testing Market by Segment, U.S., 2007 – 2017 262
Chart 9-2: Total POC Testing Market by Segment, U.S., 2010 263
Chart 9-3: Total POC Testing Market by Segment, U.S., 2017 264
Chart 9-4: Total POC Testing Market, U.S., 2007 – 2017 . 266
Chart 9-5: Total Clinical Chemistry Market, U.S., 2007 – 2017. 268
Chart 9-6: Clinical Chemistry Analyzer Market, U.S., 2007 – 2017 . 271
Chart 9-7: Clinical Chemistry Reagent Market, U.S., 2007 – 2017 .. 274
Chart 9-8: Blood Gas Testing Market, U.S., 2007 – 2017 . 276
Chart 9-9: Total Blood Gas Analyzer Market, U.S., 2007 – 2017.. 279
Chart 9-10: Handheld Blood Gas Analyzer Market, U.S., 2007 – 2017 .. 282
Chart 9-11: Decentralized Blood Gas Analyzer Market, U.S., 2007 – 2017 .. 285
Chart 9-12: Total Blood Gas Reagent Market, U.S., 2007 – 2017 . 291
Chart 9-13: Single-Use Cartridge Market, U.S., 2007 – 2017.. 292
Chart 9-14: Multi-Use Cartridge Market, U.S., 2007 – 2017 293
Chart 9-15: Other Reagent Market, U.S., 2007 – 2017 294
Chart 9-16: POC Urinalysis Market, U.S., 2007 – 2017 . 296
Chart 9-17: Urinalysis Analyzer Market, U.S., 2007 – 2017 299
Chart 9-18: POC Urinalysis Test Strip Market, U.S., 2007 – 2017 302
Chart 9-19: POC Blood Glucose Testing Market, U.S., 2007 – 2017 304
Chart 9-20: POC Blood Glucose Analyzer Market, U.S., 2007 – 2017 307
Chart 9-21: POC Blood Glucose Test Strip Market, U.S., 2007 – 2017 .. 310
Chart 9-22: Leading Competitors, Point-of-Care Testing Market, 2010.. 319
ABBREVIATIONS 320
APPENDIX: MARKET BREAKDOWN BY TESTING SETTING 322
To order this report:
In Vitro Diagnostic Industry: U.S. Market for In-Vitro Diagnostics 2011
In Vitro Diagnostic Business News
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article